Cargando…
P052. Patient's subjective judgement on the ease of use, speed of onset of action, efficacy and tolerability of Diclofenac sodium HPβCD (25 mg/mL) solution for subcutaneous injection vs Diclofenac potassium 50 mg for oral solution for the acute treatment of migraine
Autores principales: | Evangelista, Maurizio, Piseddu, Francesco Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Milan
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4715154/ https://www.ncbi.nlm.nih.gov/pubmed/28132224 http://dx.doi.org/10.1186/1129-2377-16-S1-A164 |
Ejemplares similares
-
Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis
por: Roth, Sanford H, et al.
Publicado: (2011) -
Pharmacokinetics and Safety of a Diclofenac Sodium 75 mg/1 mL Solution (Akis(®)/Dicloin(®)) Administered as a Single Intravenous Bolus Injection in Healthy Men and Women
por: Leuratti, Chiara, et al.
Publicado: (2019) -
25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study
por: Yoshihara, Takeo, et al.
Publicado: (2015) -
Relative Bioavailability and Bioequivalence of Brivaracetam 10 mg/mL Oral Solution and 50‐mg Film‐Coated Tablet
por: Otoul, Christian, et al.
Publicado: (2016) -
Pharmacokinetics of Diclofenac and Hydroxypropyl‐β‐Cyclodextrin (HPβCD) Following Administration of Injectable HPβCD‐Diclofenac in Subjects With Mild to Moderate Renal Insufficiency or Mild Hepatic Impairment
por: Hamilton, Douglas A., et al.
Publicado: (2017)